Skip to main content
All lobbying filings

MUSCULAR DYSTROPHY ASSOCIATION, INC.

Lobbying for MUSCULAR DYSTROPHY ASSOCIATION, INC.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $250,000.00 expenses · posted Jan 28, 2026

Official filing document

 Bills named in this filing 1
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 12
Health Issues

Supported the Accelerating Kids' Access to Care Act Supported a joint request for Fiscal Year 2026 Appropriations for ALS Programs Supported Pharmacy Benefit Manager (PBM) Reform Patient Priorities Expressed opposition to effort that caps indirect costs in NIH grants to 15% Supported efforts to add FSHD to the Peer Reviewed Medical Research Program Supported the reauthorization of the Rare Pediatric Disease PRV Program as part of the Gives Kids a Chance Act Continued efforts to reauthorize the ACT for ALS Supported the reintroduction of the MVP Act Supported the reintroduction of the Patient Access Act Supported the introduction of legislation that would better facilitate wheelchair repair Supported the ABC Act Supported legislation that increases access to home and community-based services Supported the HEARD Act Joined Coalition Comments to U.S. FDA for Feedback on Prescription Drug User Fee Act (PDUFA) VIII Stakeholder Consultation Meetings Joined Coalition Comments for Passage of the Senate FY 2026 Labor, Health and Human Services, Education, and Related Agencies Appropriations Bill Filed Comments re: Senate Special Committee on Aging Hearing "Aging in Place: The Impact of Community during the Holidays" Filed Comments re: Urgent Consideration of Enhanced Premium Tax Credits (eAPTCs) Extension and Labor/HHS Appropriations Filed Comments re: Senate Finance Committee Hearing: The Rising Cost of Health Care: Considering Meaningful Solutions for All Americans Filed Comments re: House Ways and Means Subcommittee Hearing: Modernizing Care Coordination to Prevent and Treat Chronic Disease (11.19.2025) Joined Coalition Comments re: Senate Finance Committee Hearing: The Rising Cost of Health Care: Considering Meaningful Solutions for All Americans Joined Coalition Comments re: House Ways and Means Subcommittee Hearing: Modernizing Care Coordination to Prevent and Treat Chronic Disease Joined Coalition Comments to FDA Urging Use of the Accelerated Approval Pathway for LGMD Therapies Joined Coalition Comments Urging Congress to Find a Solution to Expiration of eAPTCs Joined Coalition Comments Calling on Appropriations Leaders to Finalize NIH Funding Joined Coalition Comments Re: Support for the Medicare Orthotics & Prosthetics Patient-Centered Care Act Joined Coalition Comments to Centers for Medicare and Medicaid Services (CMS) Administrator Oz on Implementation of New Community Engagement Requirements Enacted by H.R. 1 Joined Coalition Comments to Administration Officials Regarding Junk Insurance Plans Marketplace Integrity and Affordability Rule Advocated for the finalization of the Muscular Dystrophy Coordinating Committee action plan Advocated for the passage of the Newborn Screening Saves Lives Act

Aviation/Airlines/Airports

Encouraged Congress to maintain its oversight of the implementation of the FAA Reauthorization Act of 2024.

Budget/Appropriations

Supported a joint request for Fiscal Year 2026 Appropriations for ALS Programs Supported efforts to add FSHD to the Peer Reviewed Medical Research Program Supported robust appropriations for the NIH, CDC, FDA, and other critical agencies for our community Joined Coalition Comments for Passage of the Senate FY 2026 Labor, Health and Human Services, Education, and Related Agencies Appropriations Bill Joined Coalition Comments Calling on Appropriations Leaders to Finalize NIH Funding

Medical/Disease Research/Clinical Labs

Expressed opposition to effort that caps indirect costs in NIH grants to 15% Supported efforts to add FSHD to the Peer Reviewed Medical Research Program Supported the reauthorization of the Rare Pediatric Disease PRV Program as part of the Gives Kids a Chance Act Continued efforts to reauthorize the ACT for ALS Joined Coalition Comments to U.S. FDA for Feedback on Prescription Drug User Fee Act (PDUFA) VIII Stakeholder Consultation Meetings Joined Coalition Comments to FDA Urging Use of the Accelerated Approval Pathway for LGMD Therapies Advocated for the finalization of the Muscular Dystrophy Coordinating Committee action plan

Medicare/Medicaid

Opposed the One Big Beautiful Bill Act Supported the Accelerating Kids' Access to Care Act Supported the reintroduction of the MVP Act Supported the reintroduction of the Patient Access Act Supported the reintroduction of the ALS Better Care Act Supported the reintroduction of the Access to Genetic Counseling Services Act Joined Coalition Comments Re: Support for the Medicare Orthotics & Prosthetics Patient-Centered Care Act Joined Coalition Comments to Centers for Medicare and Medicaid Services (CMS) Administrator Oz on Implementation of New Community Engagement Requirements Enacted by H.R. 1 Supported the ABC Act

Insurance

Supported the Accelerating Kids' Access to Care Act Opposed the One Big Beautiful Bill Act Supported the reintroduction of the Patient Access Act Filed Comments re: Urgent Consideration of Enhanced Premium Tax Credits (eAPTCs) Extension and Labor/HHS Appropriations Joined Coalition Comments Urging Congress to Find a Solution to Expiration of eAPTCs Joined Coalition Comments Re: Renewing Expiring Enhanced Premium Tax Credits (eAPTCs) Joined Coalition Comments to Administration Officials Regarding Junk Insurance Plans Marketplace Integrity and Affordability Rule

Transportation

Joined Coalition Comments re: Accessibility Considerations to Ensure Access and Safety for Disabled Travelers in Autonomous Vehicle Legislation and Provisions in Surface Transportation Reauthorization Supported the DATA Act

Education

Joined Coalition Comments Calling for Senate Oversight Hearing re: Department of Education RIFs & Impacts on Individuals with Disabilities Education Act and Section 504 of the Rehabilitation Act of 1973 Joined Coalition Comments Calling for Reversal of Layoffs at U.S. Department of Education and Impacts on the Disability Community Joined Coalition Comments to Secretary of Education McMahon Re: The Use of the Phrase Special Needs in Official U.S. Department of Education Communications Advocated for the IDEA Full Funding Act Advocated for a resolution celebrating the 50th anniversary of the IDEA

Retirement

Filed Comments re: Senate Special Committee on Aging Hearing "Aging in Place: The Impact of Community during the Holidays" Advocated for the Social Security Claims Processing Improvement Act Supported the ABC Act

Pharmacy

Supported Pharmacy Benefit Manager (PBM) Reform Patient Priorities

Immigration

Joined Coalition Comments to U.S. Dept. of Homeland Security on Proposed Public Charge Ground of Inadmissibility Rule

Consumer Issues/Safety/Products

Joined Coalition Comments to U.S. Consumer Financial Protection Bureau re: Fair Credit Reporting Act (FCRA) Guidance

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem